Drupal.behaviors.print = function(context) {window.print();window.close();}>
OvaGene Licenses miRNA Technology from Moffitt for Drug Response Assays
December 06, 2011
OvaGene Licenses miRNA Technology from Moffitt for Drug Response Assays
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Gradalis Releases New Clinical Data on Cancer Vaccine
May 16, 2013 / Gene Silencing News
Dicerna Licenses Gene Silencing IP from Plant Bioscience Limited
April 11, 2013 / Gene Silencing News
Oxford Gene Technology Licenses ICR Prostate Cancer Biomarker Panel
March 13, 2013 / GenomeWeb Daily News
NIH Awards Johns Hopkins Spinout Circulomics $800K for MicroRNA Tech Development
December 10, 2012 / GenomeWeb Daily News
Chicago Team Finds miRNAs Convert Fibroblasts around Ovarian Tumors to Promote Cancer
November 29, 2012 / Gene Silencing News